0

10. Cancers attributable to exposure to hormones in the UK in 2010

Parkin DM, 2011

British journal of cancer, 105 Suppl 2(Suppl 2), S42-S48

DOI 10.1038/bjc.2011.483 PMID 22158320 Source

Abstract

The International Agency for Research on Cancer (IARC) Monographs on the carcinogenic risk to humans concluded that combined oral oestrogen–progestogen contraceptives are carcinogenic to humans (IARC, 2007). This evaluation was made on the basis of increased risks for cancer of the breast (among current and recent users only), cervix and liver (in populations that are at low risk for hepatitis B viral infection). There is also convincing evidence in humans that these agents confer a protective effect against cancer of the endometrium and ovary.

Topics

Contraception/Comparison > Side Effects > Hormonal ContraceptionContraception/Comparison > FABM vs Hormonal > Side Effects
hormonal contraception cancer risk, birth control pill breast cancer, oral contraceptive cervical cancer, combined hormonal contraceptive carcinogenic, hormone replacement therapy cancer, contraceptive protective effect ovarian cancer, endometrial cancer oral contraceptives, liver cancer hormonal contraception, long-term risks birth control pills

Cite this article

Parkin, D. M. (2011). 10. Cancers attributable to exposure to hormones in the UK in 2010. *British journal of cancer*, *105 Suppl 2*(Suppl 2), S42-8. https://doi.org/10.1038/bjc.2011.483

Keywords

Adolescent, Adult, Breast Neoplasms, Contraceptives, Oral, Combined, Hormonal, Endometrial Neoplasms, Female, Hormone Replacement Therapy, Hormones, Humans, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Risk, Time Factors, United Kingdom, Uterine Cervical Neoplasms

Related articles